TABLE 3.
2-Drug | 3-Drug | Total | 2 vs. 3 | Subgroup | |
---|---|---|---|---|---|
Overall | 54% | 41% | 48% | NS | |
1st Transplant | 49% | 36% | 43% | NS | P < .04 |
Retransplantation | 66% | 53% | 59% | NS | |
Cadaveric | 61% | 43% | 51% | P < .02 | P < .007 |
Living-donor | 22% | 25% | 23% | NS | |
PRA <40% | 49% | 35% | 43% | NS | P < .002 |
PRA >40% | 80% | 64% | 70% | NS | |
No ATN | 43% | 34% | 39% | NS | P < .001 |
ATN | 69% | 54% | 62% | NS | |
Black | 85% | 67% | 75% | NS | P < .002 |
Nonblack | 49% | 37% | 43% | NS | |
Donors >60 years | 62% | 50% | 57% | NS | NS |
Donors < 60 years | 53% | 40% | 46% | NS | |
Recipients <60 years | 55% | 45% | 50% | NS | NS |
Recipients >60 years | 46% | 27% | 33% | NS |